Zulvac 8 Bovis

RSS

inactivated bluetongue virus, serotype 8

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 24/11/2020

Authorisation details

Product details
Name
Zulvac 8 Bovis
Agency product number
EMEA/V/C/000145
Active substance
inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02
International non-proprietary name (INN) or common name
inactivated bluetongue virus, serotype 8
Species
Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI02AA08
Publication details
Marketing-authorisation holder
Zoetis Belgium SA 
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
15/01/2010
Contact address

Zoetis Belgium SA
Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Product information

23/03/2017 Zulvac 8 Bovis - EMEA/V/C/000145 - IG/0747

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of cattle from three months of age for the prevention of viraemia caused by bluetongue virus, serotype 8.

Assessment history

News

How useful was this page?

Add your rating